SCHEMBL4256804

SCHEMBL4256804

COC(=O)c1cc(Cl)c(NC(C)=O)c(N)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.49
KDM4E B2RXH2 7/20 0.47
POLB P06746 2/20 0.47
HPGD P15428 2/20 0.43
ALDH1A1 P00352 3/20 0.41
ABL1 P00519 1/20 0.41
USP2 O75604 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NQO2 P16083 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
IDO1 P14902 1/20 0.40
HTT P42858 1/20 0.40
CDK1 P06493 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
GALK1 P51570 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319755 0.89 ALDH1A1 (0.41) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL10471900 0.85 HPGD (0.45) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL30885715 0.85 HPGD (0.45) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL7365868 0.83 HPGD (0.43) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL13255342 0.82 GAA (0.57) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL10472303 0.80 GAA (0.55) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL1116032 0.79 SMN1; SMN2 (0.44) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL6771563 0.79 KDM4E (0.58) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL7852188 0.77 KDM4E (0.57) GAAKDM4EPOLBHPGDALDH1A1
SCHEMBL7414157 0.77 GALK1 (0.39) GAAKDM4EPOLBHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors CORBETT JEFFREY WAYNE 2009-10-29 US disclosed
CN-101541809-A Spiroketone acetyl-CoA carboxylase inhibitors PFIZER PROD INC (US) 2009-09-23 CN disclosed
EP-2097420-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS Pfizer Products Inc. (US) 2009-09-09 EP disclosed
WO-2008065508-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS PFIZER PRODUCTS INC. (US) 2008-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, PC, ACACB GAA 1471/4885KDM4E 1062/4885POLB 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.